NeuEve Unveils New Approach to Chronic Yeast Infections

ARLINGTON HEIGHTS, IL – April 09, 2026 – As millions of women navigate the frustrating cycle of recurrent yeast infections, a new product from research lab NeuEve aims to shift the treatment paradigm from simple eradication to holistic microbiome support. The company today announced the launch of Yeast Clear, a 100% natural vaginal suppository developed to address the root causes of chronic candidiasis, a condition that affects an estimated 138 million women worldwide.

The move comes as a response to a significant unmet need in women's health. While 75% of women will experience at least one yeast infection in their lifetime, a staggering 45% face repeat occurrences. For this group, conventional treatments often provide only temporary relief, with recurrence rates as high as 30-50% after therapy ceases. This cycle has fueled a search for more sustainable solutions, particularly as concerns grow over antifungal resistance to common medications like fluconazole.

"The high recurrence rate from all other treatments is an opportunity for us to make a positive impact on society," said Dr. Renjie Chang, the OBGYN and medical scientist who invented the new product.

A Cycle of Frustration and Recurrence

For the 5-8% of women who suffer from recurrent vulvovaginal candidiasis (RVVC)—defined as four or more episodes a year—the battle can feel endless. Standard over-the-counter and prescription antifungal medications, while effective in the short term, often fail to prevent the infection's return. These treatments are designed to kill the overgrown Candida fungus but don't always address the underlying imbalance that allowed the overgrowth in the first place.

Alternative treatments like boric acid have gained popularity for recurrent cases, but they are not without drawbacks. While effective at killing pathogens, boric acid can be harsh, potentially irritating sensitive vaginal tissues and indiscriminately eliminating both harmful and beneficial bacteria. This "bomb everyone" approach can disrupt the delicate vaginal microbiome, a complex ecosystem crucial for maintaining health and preventing infections. Without a healthy population of protective bacteria, the vaginal environment remains vulnerable to future overgrowths, perpetuating the cycle of infection.

This is the gap NeuEve aims to fill. The company's philosophy moves beyond simply waging war on a single pathogen and instead focuses on re-establishing a healthy, self-regulating vaginal environment.

Beyond the Battlefield: A New Strategy for Vaginal Health

Yeast Clear introduces a mechanism NeuEve calls "environmental change & microbiome support." The strategy is twofold: first, suppress the yeast overgrowth using a potent blend of natural botanicals, and second, nourish the vagina's natural defenders—the beneficial Lactobacillus bacteria.

Kevin Tao, co-founder of NeuEve, explained the concept with a powerful analogy. "In World War II, how did we defeat our enemies in Occupied France? We didn't bomb everyone (friend & foe). That's what boric acid does," he stated. "We didn't bomb only the enemies. That's what other over-the-counter antifungal treatments do."

Instead, NeuEve's approach mirrors a more strategic operation. "We must: 1. Bomb the enemies, with powerful natural antifungals. 2. Next, airdrop supplies to French resistance fighters, with nutrients that feed good lactobacilli... 3. Finally, storm the beaches with our vaginal probiotics."

This "airdrop" of specialized nutrients is a key differentiator. The nutrients are selected to exclusively feed beneficial Lactobacilli. As these protective bacteria flourish, they produce lactic acid, which lowers the vaginal pH. This acidic environment is inhospitable to Candida and other pathogens, creating a natural, long-term defense system that helps prevent future infections.

Nature's Arsenal: The Science of Botanical Antifungals

The "bombing" phase of NeuEve's strategy relies on a high-dose combination of botanical extracts long recognized for their antimicrobial properties. The formulation includes olive leaf, sage, tea tree oil, neem, myrtle, and plantain.

Scientific literature lends support to the efficacy of these ingredients. In vitro studies have shown that:
* Olive Leaf Extract, containing the compound oleuropein, demonstrates potent activity against Candida albicans, inhibiting its growth and damaging its cell structure.
* Tea Tree Oil has well-documented antifungal properties and has proven effective against drug-resistant Candida strains in lab settings.
* Neem Oil has been shown to be effective against C. albicans without inducing the microbial resistance sometimes seen with conventional drugs.
* Sage, Myrtle, and Plantain extracts have also exhibited inhibitory effects against Candida in various test-tube studies, interfering with its growth and biofilm formation.

By combining these natural agents, Yeast Clear aims to reduce the yeast population without the harshness of synthetic chemicals, paving the way for the microbiome-supporting phase of the treatment.

A Founder's Mission to End 'Unsolvable Cases'

The impetus for Yeast Clear came directly from the clinic. Dr. Renjie Chang, an OBGYN with over three decades of experience, grew frustrated seeing patients trapped in a cycle of recurring infections. These were women who had already exhausted every available treatment option without finding lasting relief.

"A lot of other doctors have given up on these women. When it comes to helping others, I never give up," said Dr. Chang. Her resolve to find a solution for these "unsolvable cases" became the driving force behind the product's invention. "When other doctors say: 'But I have no tools left,' I say: 'Then I will make my own tools.'"

This mission-driven approach is a hallmark of NeuEve, which has previously developed natural products for bacterial vaginosis (BV) and vaginal atrophy, a condition often affecting post-menopausal women and cancer survivors. The company's products for severe vaginal dryness have reportedly been observed by physicians at Massachusetts General Hospital to provide significant relief for patients treated with radiation.

NeuEve positions its products as natural alternatives, similar to nutraceuticals, and relies on extensive "product evaluation studies" based on customer feedback to assess safety and effectiveness, rather than the formal Phase III clinical trials required for pharmaceutical drugs. This approach aligns with a growing consumer demand for natural, gentle health solutions, placing Yeast Clear at the intersection of medical innovation and the wellness movement.

"It is my hope that by listening to women, and using first principles, root-cause analysis to solve their issues, I can be a good example for others to follow," Dr. Chang stated. For the millions of women seeking an end to chronic yeast infections, this new approach offers a potential pathway not just to relief, but to restoring the body's own ability to maintain balance and health.